adverse drug reaction following injection of amikacin sulphate in a cluster of preterm newborns
Clicks: 277
ID: 213872
2017
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This
article has not been analysed, so there is no overall score —
reader engagement is measured and shown alongside.
Reader Engagement
Steady Performance
30.0
/100
277 views
31 readers
AI Quality Assessment
Not analyzed
Readership in this journal
SteadyRanked #13 of 18 articles by views in neuropsychopharmacology : official publication of the american college of neuropsychopharmacology
Most read
Least read
Bar heights use a square-root scale.
Mint this article as an NFT
Not yet mintedCreate a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.
5
SUSD
one-off · no wallet required
Abstract
Although, single case reports regarding adverse effects of
Inj. Amikacin sulphate in newborns have been published,
simultaneous affection of multiple babies is rare. In this
report we present cluster of newborns admitted in a neonatal
intensive care setup presenting with Adverse Drug Reaction
(ADR) to Inj. Amikacin sulphate. It can cause life threatening
adverse effects and neonates are particularly vulnerable to
ADR.
| Reference Key |
varia2017adverse
Use this key to autocite in the manuscript while using
SciMatic Manuscript Manager or Thesis Manager
|
|---|---|
| Authors | ;Jayesh Varia;Rajiv Prasad;Vandana M Desai;Vasav D Desai |
| Journal | neuropsychopharmacology : official publication of the american college of neuropsychopharmacology |
| Year | 2017 |
| DOI |
10.7860/IJNMR/2017/27702.2217
|
| URL | |
| Keywords |
Citations
No citations found. To add a citation, contact the admin at info@scimatic.org
Comments
No comments yet. Be the first to comment on this article.